[Experimental anti-inflammatory action of SQ-20385].
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000633:toxicity; D001623:Betamethasone / Q000627:therapeutic use / Q000633:toxicity; D002199:Capillary Permeability / Q000187:drug effects*; D005260:Female; D066298:In Vitro Techniques; D007249:Inflammation / Q000188:drug therapy*; D008247:Lysosomes / Q000187:drug effects*; D008297:Male; D008566:Membranes / Q000187:drug effects; D009539:Nicotinic Acids; D051381:Rats
D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; C003828:SQ 20385; D001623:Betamethasone
Acción antiinflamatoria experimental del SQ-20385.